Peter Donato

4PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markersSystems physiologyMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 23, 2020
68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer.

Matthew J Roberts, Andrew Morton, Peter Donato

|Jun 20, 2020
Management of benign prostatic hyperplasia in the 21st century: temporal trends in Australian population-based data.

Andrew Morton, Michael Williams, Marlon Perera

|Jan 09, 2020
68Ga-PSMA PET/CT better characterises localised prostate cancer after MRI and transperineal prostate biopsy: Is 68Ga-PSMA PET/CT guided biopsy the future?

Peter Donato, Andrew Morton, John Yaxley

Pageof 1